Second Quarter Total Revenue in the Range of $10.0 Million to $10.2 Million, an Increase of Approximately 12-15% Over the Same Period Last Year. BELGRADE, Mont. , July 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone

BELGRADE, Mont. , June 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE) has been awarded a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier, Inc. Effective July 1st, 2015 , the new agreement allows Premier

BELGRADE, Mont. , June 19, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the signing of an agreement with Yankee Alliance , a group purchasing organization (GPO) with more than 11,500 members.

BELGRADE, Mont. , June 3, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary biomaterials, today announced the release of ArthroFuse, a patent pending allograft specifically designed for the treatment of hammertoe deformities.

BELGRADE, Mont. , May 15, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bacterin stockholders of record at the close of

Company Continues to See Record Revenue Growth, Gross Profit Increases and Improved Gross Margins First Quarter Highlights: Total revenue increased 6.6% to $9.5 million from $8.9 million reported in first quarter of 2014 Gross profit increased 9.6% to $6.0 million compared to $5.5 million reported

BELGRADE, Mont. , May 4, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has established a record date for its 2015 annual meeting of stockholders. Bacterin stockholders of record at the close of business

BELGRADE, Mont. , April 28, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary allograft, today announced that its Acellular Dermal Matrix allograft (ADM), hMatrix®, has received coverage from Novitas Solutions, Inc.

BELGRADE, Mont. , April 23, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended March 31, 2015 , on May 5, 2015 at the close of

First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year BELGRADE, Mont. , April 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of